目的将在 FOLFOX 化疗期间为临床的症状的缓和调查 qi-yin-reinforcing 粥的饮食的治疗的功效。单个盒子的使随机化的控制研究被执行的方法。有接受 FOLFOX 化疗的胃肠的肿瘤的十四个病人用自我转线路控制设计被注册。在天象 qi-yin-reinforcing 粥的 17 化疗,试验性的组和安慰剂控制组被给有一样的外观的 qi-yin-reinforcing 粥和准备糊精的粥的饮食的治疗的饮食的治疗,味觉,颜色和味觉分别地。十四临床的症状包括衰弱,呕吐并且恶心,等等被观察。结果十个病人完成了学习并且是可敬的。qi-yin-reinforcing 粥在在化疗的经期期间与胃肠的肿瘤减轻病人的临床的症状表明了某些功效。减轻衰弱的更好的效果比在安慰剂控制组在饮食的治疗被发现试验性的组,并且差别是统计上重要的(Z=2.27, P=0.02 ) 。没有统计上重要的差别关于包括厌食,恶心,呕吐、干燥凳子,松开的凳子,等等和身体重量减轻另外的 13 临床的症状的效果在试验性的组和控制组之间被发现(P > 0.05 ) 。qi-yin-reinforcing 粥的结论饮食的治疗在在化疗期间减轻病人的衰弱显示出一个另外的好处并且值得临床的使用和通俗化。
Objective: To investigate the efficacy of dietary therapy of qi-yin-reinforcing porridge for the alleviation of clinical symptoms during FOLFOX chemotherapy. Methods: A single-case randomized controlled study was carded out. Fourteen patients with gastrointestinal tumors accepting FOLFOX chemotherapy were enrolled using self-crossover control design. On days 1-7 of chemotherapy, the dietary therapy expedmental group and the placebo control group were given dietary therapy of qi-yin-reinforcing porridge and dextrin-prepared porridge which had the same appearance, smell, color and taste as the qi-yin-reinforcing porridge, respectively. Fourteen clinical symptoms, including debility, vomiting and nausea, etc. were observed. Restdts: Ten patients completed the study and were estimable. The qi-yin-reinforcing porridge demonstrated certain efficacy in alleviating clinical symptoms of patients with gastrointestinal tumors during the pedod of chemotherapy. Better effect of alleviating debility was found in the dietary therapy expedmantal group than in the placebo control group, and the difference was statistically significant (Z=2.27, P=0.02). No statistically significant difference was found between the experimental group and the control group with respect to the effect of alleviating the other 13 clinical symptoms including anorexia, nausea, vomiting, dry stool, loose stool, etc. and body weight (P〉0.05). Conclusion: Dietary therapy of qi-yin-reinforcing porridge shows an additional benefit in alleviating debility of patients during chemotherapy and deserves clinical use and popularization.